Riskpilot← Back to searchSign inGet full accessKILAIDAKIS vård AB
ABActiveOrg 5590049952Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20150 employees
Revenue 2025
SEK 1
EBITDA margin
-3762200.0%
+59% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
SEK 2M
+79% vs 2024
| Revenue | SEK 1 | — |
| EBITDA | SEK -38K | +59% |
| Net profit | SEK 2M | +79% |
| Total assets | SEK 9,3M | +24% |
| Equity | SEK 9,3M | +24% |
| Employees | 0 | — |
Legal name
KILAIDAKIS vård AB
Org number
5590049952
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
24 februari 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av externa firmatecknaren
Company purpose
Sjukvård. Konsultation inom vård och vårdutbildning. Kapitalförvaltning.
Address
Email
kilaidakis@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 625 | 2 256 | 2 343 | 0 | 0 |
| Staff expenses | — | −147 | −85 | −7 | −15 |
| EBITDA | 1 284 | 1 862 | 1 888 | −93 | −38 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 284 | 1 862 | 1 888 | −93 | −38 |
| Net financials | 23 | 29 | 144 | 200 | 2 033 |
| Profit before tax | 979 | 1 663 | 2 062 | 1 409 | 1 995 |
| Tax | −203 | −348 | −434 | −303 | −20 |
| Net profit | 776 | 1 315 | 1 628 | 1 106 | 1 975 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 057 | 6 965 | 8 502 | 7 494 | 9 290 |
| Equity | 4 443 | 5 158 | 6 591 | 7 493 | 9 268 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 511 | 476 | 610 | 1 | 21 |
| Total debt | 511 | 476 | 610 | 1 | 21 |
EBITDA margin
-3762200.0%
This company
15.8%
Market median
-23811492% vs market
20212025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
21.3%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
197502300.0%
This company
8.1%
Market median
+2438299900% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS External Signatory | External Signatory | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KILAIDAKIS vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Sidney Johannes Larsson | External Signatory | 0 companies |
| Sofia Varsami | Deputy Board Member | 0 companies |
| Spyridon Kilaidakis | Board of Directors | 0 companies |